Keryx Biopharmaceuticals Inc. - KERX- Quotes & Financials

Home » Directory » Pharmaceuticals & Biotechnology » Biotechnology » Genomics » Keryx Biopharmaceuticals Inc. » Quote & Financials



Company Financials
StreetInsider.com - Keryx Biopharmaceuticals (KERX) Receives FDA ...
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced that KRX-0401 ( perifosine) has received Orphan-Drug designation from the FDA for the treatment of ...
http://www.streetinsider.com/FDA/Keryx+Biopharmaceuticals+(KERX)+Receives+FDA+Orphan...
StreetInsider.com - Keryx Biopharmaceuticals (KERX) Tops Q4 EPS by ...
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) reports a Q4 loss of $0.08 per share vs. consensus for $0.13 loss. Revenues were $327K vs. $530.00K consensus. ...
http://www.streetinsider.com/Earnings/Keryx+Biopharmaceuticals+(KERX)+Tops+Q4+EPS+by...
A Rocket Ride For Keryx Biopharmaceuticals (KERX) Shares ...
Keryx Biopharmaceuticals (KERX) shares rode up 50% on volume that topped 10 million shares just after 10.30 EST. The company and Aeterna Zentaris will ...
http://www.biohealthinvestor.com/2009/08/a-rocket-ride-for-keryx-biopharmaceuticals-...
KERX Stock Quote | Keryx Biopharmaceuticals Research
Keryx Biopharmaceuticals (KERX). CAPS Rating: 3 out of 5. A biopharmaceutical company focused on the acquisition, development and ...
http://caps.fool.com/Ticker/KERX.aspx
Related Business Topics
Overview  |  Profile  |  News  |  Quote & Financials